DS
CLSD

DRW Securities’s Clearside Biomedical CLSD Stock Holding History

DRW Securities’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.26K Hold
27,136
– – ﹤0.01% 910
2026
Q1 		$7.87K Hold
27,136
– – ﹤0.01% 1221
2025
Q4 		$19.1K Buy
+27,136
New +$95.6K ﹤0.01% 1168
2018
Q2 		– Sell
-1,000
Closed -$161K – 110
2018
Q1 		$161K Buy
+1,000
New +$122K 0.01% 132

DRW Securities's CLSD Position: Q2 2026 in Review

DRW Securities held its Clearside Biomedical (CLSD) position steady in Q2 2026 at 27,136 shares worth $3.26K. The position accounts for ﹤0.01% of the portfolio, ranked #910.

DRW Securities first reported a position in CLSD in Q1 2018 and has held it in 4 quarters since. The position peaked at $161K in Q1 2018. 1 fund tracked by Wall St. Rank holds CLSD as of Q2 2026.

  • DRW Securities held 27,136 shares of Clearside Biomedical worth $3.26K as of Q2 2026.
  • DRW Securities left its Clearside Biomedical share count unchanged in Q2 2026.
  • Clearside Biomedical made up ﹤0.01% of DRW Securities's portfolio in Q2 2026, its #910 holding.
  • DRW Securities first reported a position in Clearside Biomedical in Q1 2018 and has held it in 4 quarters since.
  • DRW Securities's Clearside Biomedical position peaked at $161K in Q1 2018.
  • 1 fund tracked by Wall St. Rank held Clearside Biomedical as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.